Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 30, 2016
A multifunctional CT technology: Reality or illusion for patient risk assessment?Tomoaki Nakata
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2015
Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in JapanKenichi Nakajima, Tomoaki Nakata
BMJ Open|December 17, 2020
Translation, adaptation and validation of the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) for use in Japan: a multicentre cross-sectional studyTakuya Aoki, Yosuke Yamamoto, Tomoaki Nakata
Circulation Journal : Official Journal of the Japanese Circulation Society|December 8, 2015
Prognostic Value of Cardiac Sympathetic Nerve Imaging Using Long-Term Follow-up Data - Ischemic vs. Non-Ischemic Heart Failure EtiologyShinro Matsuo, Kenichi Nakajima, Tomoaki Nakata
Current Heart Failure Reports|October 5, 2013
Cardiac metaiodobenzylguanidine imaging and heart failureTomoaki Nakata, Akiyoshi Hashimoto, Hirohito Sugawara
Diabetes Care|January 28, 2003
Insulin sensitivity and lipid metabolism in human CD36 deficiencyMasato Furuhashi, Nobuyuki Ura, Tomoaki Nakata, et al.
European Heart Journal. Cardiovascular Imaging|February 4, 2017
Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fractionTakahiro Doi, Tomoaki Nakata, Satoshi Yuda, et al.
ESC Heart Failure|January 23, 2020
Synergistic prognostication of left ventricular hypertrophy and three-dimensional mechanical dyssynchrony in heart failureTakahiro Doi, Tomoaki Nakata, Satoshi Yuda, et al.
Clinical Nuclear Medicine|September 24, 2020
Dynamic Whole-Body 18F-FDG PET for Minimizing Patient Motion ArtifactTomohito Kaji, Kouji Osanai, Tomoaki Nakata, et al.
European Heart Journal. Cardiovascular Imaging|December 26, 2015
Creation of mortality risk charts using 123I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2- and 5-year risk modelsKenichi Nakajima, Tomoaki Nakata, Shinro Matsuo, et al.
Pageof 7